For chronic heart failure with reduced ejection fraction, for the treatment of essential hypertension
Conditions
Interventions
Sacubactril valsartan sodium tablets standard dose group:NA
Sponsors
Wenzhou peoples hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. It is clinically suitable for patients with sakubactril valsartan sodium tablets; 2. Obtain the informed consent and signature of the patient or guardian
Exclusion criteria
Exclusion criteria: 1. There are any contraindications or other circumstances that prohibit the use of sarcubatrol valsartan sodium tablets according to the contraindications and precautions listed in the instruction manual approved by Sarcubatrol Valsartan sodium tablets; 2, poor compliance, unable to complete or refuse to complete the interviewer; 3. Patients with mental disorders and other factors affecting compliance; 4, known allergy to the components of this drug; 5. Researchers believe that candidates are not suitable for admission
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood routine;Liver function;Renal function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse event; | — |
Countries
China
Contacts
Public ContactXiaoshu Chen
Wenzhou People's Hospital
Outcome results
None listed